Jean-Yves Pierga (Jean Yves-Pierga)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Simultaneous Determination

Neoadjuvant Chemotherapy

Circulating Tumor

Metastatic Breast Cancer

Top Venues

British journal of cancer

NPJ breast cancer

JMIR research protocols

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron, Noemie Girard, Lea Pauly, Elodie Gauroy, Lauren Darrigues, Beatriz Grandal, Jean-Yves Pierga, Anne-Sophie Hamy-Petit, Fabien Reyal, Enora Laas
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. British journal of cancer 130 (7) (2024)
Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron, Noemie Girard, Lea Pauly, Elodie Gauroy, Lauren Darrigues, Beatriz Grandal, Jean-Yves Pierga, Anne-Sophie Hamy-Petit, Fabien Reyal, Enora Laas
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. British journal of cancer 130 (7) (2024)
Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron, Noemie Girard, Lea Pauly, Elodie Gauroy, Lauren Darrigues, Beatriz Grandal, Jean-Yves Pierga, Anne-Sophie Hamy-Petit, Fabien Reyal, Enora Laas
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. British journal of cancer (2024)
Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron, Noemie Girard, Lea Pauly, Elodie Gauroy, Lauren Darrigues, Beatriz Grandal, Jean-Yves Pierga, Anne-Sophie Hamy-Petit, Fabien Reyal, Enora Laas
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. British journal of cancer 130 (7) (2024)
Thomas Gaillard, Jeanne Piketty, Jean-Guillaume Feron, Noemie Girard, Lea Pauly, Elodie Gauroy, Lauren Darrigues, Beatriz Grandal, Jean-Yves Pierga, Anne-Sophie Hamy-Petit, Fabien Reyal, Enora Laas
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib. British journal of cancer 130 (7) (2024)
Komal L Jhaveri, Elgene Lim, Rinath M Jeselsohn, Cynthia X Ma, Erika Paige Hamilton, Cynthia Osborne, Manali Bhave, Peter A Kaufman, J Thaddeus Beck, Luis Manso Sanchez, Ritesh Parajuli, Hwei-Chung Wang, Jessica J Tao, Seock-Ah Im, Kathleen K Harnden, Kan Yonemori, Ajay Dhakal, Patrick Neven, Philippe Aftimos, Jean-Yves Pierga, Yen-Shen Lu, Timothy Larson, Yolanda Jerez, Kostandinos Sideras, Joo Hyuk Sohn, Sung-Bae Kim, Cristina Saura, Aditya Bardia, Sarah L Sammons, Francesca Bacchion, Yujia Li, Eunice Yuen, Shawn T Estrem, Vanessa Rodrik-Outmezguine, Bastien Nguyen, Roohi Ismail-Khan, Lillian M Smyth, Muralidhar Beeram
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Anne Brédart, Aude Rault, Johanna Terrasson, Etienne Seigneur, Leanne De Koning, Elisabeth Hess, Alexia Savignoni, Paul-Henri Cottu, Jean-Yves Pierga, Sophie Piperno-Neumann, Manuel J Rodrigues, Carole Bouleuc, Sylvie Dolbeault
Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study. JMIR research protocols 11 (1) (2022)
Katrina Cristall, Francois-Clement Bidard, Jean-Yves Pierga, Michael J Rauh, Tatiana Popova, Clara Sebbag, Olivier Lantz, Marc-Henri Stern, Christopher R Mueller
A DNA methylation-based liquid biopsy for triple-negative breast cancer. NPJ precision oncology 5 (1) (2021)
Amanda Bortolini Silveira, François-Clément Bidard, Marie-Laure Tanguy, Elodie Girard, Olivier Trédan, Coraline Dubot, William Jacot, Anthony Goncalves, Marc Debled, Christelle Levy, Jean-Marc Ferrero, Christelle Jouannaud, Maria Rios, Marie-Ange Mouret-Reynier, Florence Dalenc, Caroline Hego, Aurore Rampanou, Benoit Albaud, Sylvain Baulande, Frédérique Berger, Jérôme Lemonnier, Shufang Renault, Isabelle Desmoulins, Charlotte Proudhon, Jean-Yves Pierga
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer. NPJ breast cancer 7 (1) (2021)
Alexandra Bizot, Maryam Karimi, Elie Rassy, Pierre Etienne Heudel, Christelle Levy, Laurence Vanlemmens, Catherine Uzan, Elise Deluche, Dominique Genet, Mahasti Saghatchian, Sylvie Giacchetti, Juline Grenier, Anne Patsouris, Véronique Dieras, Jean-Yves Pierga, Thierry Petit, Sylvain Ladoire, William Jacot, Marc-Antoine Benderra, Anne De Jesus, Suzette Delaloge, Matteo Lambertini, Barbara Pistilli
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic. British journal of cancer 125 (11) (2021)
Antoine Vasseur, Nicolas Kiavue, François-Clément Bidard, Jean-Yves Pierga, Luc Cabel
Clinical utility of circulating tumor cells: an update. Molecular oncology 15 (6) (2020)
Marcela Carausu, Samia Melaabi, Jean-Yves Pierga, Francois-Clement Bidard, Luc Cabel
ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer. Journal of breast cancer 23 (2) (2019)